Key details
Sponsor
Closed Joint-Stock Company NeoCor
Collaborators
CT Medical Limited Liability Company, Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Enrollment target
~2,000 participants
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated September 2024